Ardelyx Inc
NASDAQ:ARDX
| Market Cap (Intraday) | 1.03B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 74.83 |
| 10-Day MA | $4.31 |
| 50-Day MA | $3.92 |
| 200-Day MA | $5.04 |
Ardelyx Inc Stock, NASDAQ:ARDX
400 Fifth Avenue, Suite 210, Waltham, Massachusetts 02451
United States of America
Phone: +1.510.745.1700
Number of Employees: 395
Description
Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.